D

Dyadic International
D

DYAI

1.19000
USD
-0.01
(-0.83%)
Market Closed
Volume
0
EPS
-0
Div Yield
-
P/E
-6
Market Cap
35,807,887
Related Instruments
A
APPS
-0.10000
(-3.23%)
3.00000 USD
C
CRBP
-0.11500
(-1.48%)
7.67500 USD
G
GLMD
0.03000
(2.40%)
1.28000 USD
K
KNSA
0.085
(0.31%)
27.765 USD
O
OGEN
0.00150
(0.79%)
0.19190 USD
T
TXG
-0.05000
(-0.59%)
8.38000 USD
V
VNRX
-0.00580
(-1.20%)
0.47920 USD
V
VSTM
-0.44000
(-5.92%)
6.99000 USD
More
News

Title: Dyadic International

Sector: Healthcare
Industry: Biotechnology
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.